NRBO - NeuroBo Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
0
0
-
-
Operating Expenses
Research Development
5,528
14,312
22,686
8,740
Selling General and Administrative
5,240
8,493
10,438
5,956
Total Operating Expenses
10,768
22,805
33,124
14,696
Operating Income or Loss
-10,768
-22,805
-33,124
-14,696
Interest Expense
-
654
-
-
Total Other Income/Expenses Net
-2,045
-178
-5
-4
Income Before Tax
-13,807
-23,637
-33,415
-14,586
Income Tax Expense
0
0
0
0
Income from Continuing Operations
-13,807
-23,637
-33,415
-14,586
Net Income
-13,807
-23,637
-33,415
-14,586
Net Income available to common shareholders
-13,807
-23,637
-33,415
-14,952
EBITDA
-
-22,805
-33,124
-14,696